Target Price | $887.40 |
Price | $725.29 |
Potential | 22.35% |
Number of Estimates | 19 |
19 Analysts have issued a price target Axon Enterprise Inc 2026 . The average Axon Enterprise Inc target price is $887.40. This is 22.35% higher than the current stock price. The highest price target is $1,050.00 44.77% , the lowest is $585.11 19.33% . | |
A rating was issued by 26 analysts: 23 Analysts recommend Axon Enterprise Inc to buy, 3 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Axon Enterprise Inc stock has an average upside potential 2026 of 22.35% . Most analysts recommend the Axon Enterprise Inc stock at Purchase. |
22 Analysts have issued a sales forecast Axon Enterprise Inc 2025 . The average Axon Enterprise Inc sales estimate is $2.8b . This is 15.86% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $2.9b 22.51% , the lowest is $2.6b 10.09% .
This results in the following potential growth metrics:
2024 | $2.1b | 33.44% |
---|---|---|
2025 | $2.8b | 33.06% |
2026 | $3.4b | 24.36% |
2027 | $4.2b | 21.01% |
19 Analysts have issued an Axon Enterprise Inc EBITDA forecast 2025. The average Axon Enterprise Inc EBITDA estimate is $695m . This is 2,192.51% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $761m 2,410.07% , the lowest is $649m 2,042.84% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $112m | 41.87% |
---|---|---|
2025 | $695m | 522.04% |
2026 | $893m | 28.61% |
2027 | $1.2b | 30.86% |
2024 | 5.36% | 56.43% |
---|---|---|
2025 | 25.07% | 367.53% |
2026 | 25.92% | 3.39% |
2027 | 28.03% | 8.14% |
20 Axon Enterprise Inc Analysts have issued a net profit forecast 2025. The average Axon Enterprise Inc net profit estimate is $532m . This is 63.15% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $642m 96.65% , the lowest is $449m 37.71% .
This results in the following potential growth metrics and future Net Margins:
2024 | $377m | 114.49% |
---|---|---|
2025 | $532m | 41.20% |
2026 | $629m | 18.11% |
2027 | $781m | 24.26% |
2024 | 18.10% | 60.74% |
---|---|---|
2025 | 19.21% | 6.11% |
2026 | 18.25% | 5.00% |
2027 | 18.74% | 2.68% |
20 Analysts have issued a Axon Enterprise Inc forecast for earnings per share. The average Axon Enterprise Inc EPS is $6.84 . This is 72.29% higher than earnings per share in the financial year 2024. The highest EPS forecast is $8.24 107.56% , the lowest is $5.77 45.34% .
This results in the following potential growth metrics and future valuations:
2024 | $4.80 | 106.01% |
---|---|---|
2025 | $6.84 | 42.50% |
2026 | $8.08 | 18.13% |
2027 | $10.04 | 24.26% |
Current | 182.69 | 172.81% |
---|---|---|
2025 | 106.06 | 41.95% |
2026 | 89.80 | 15.33% |
2027 | 72.27 | 19.52% |
Based on analysts' sales estimates for 2025, the Axon Enterprise Inc stock is valued at an EV/Sales of 20.47 and an P/S ratio of 20.55 .
This results in the following potential growth metrics and future valuations:
Current | 23.71 | 97.91% |
---|---|---|
2025 | 20.47 | 13.68% |
2026 | 16.46 | 19.59% |
2027 | 13.60 | 17.36% |
Current | 23.81 | 95.90% |
---|---|---|
2025 | 20.55 | 13.69% |
2026 | 16.52 | 19.59% |
2027 | 13.65 | 17.36% |
Axon Enterprise Inc...
Analyst | Rating | Action | Date |
---|---|---|---|
B of A Securities |
Buy
➜
Buy
|
Unchanged | Aug 06 2025 |
UBS |
Neutral
➜
Neutral
|
Unchanged | Aug 05 2025 |
Craig-Hallum |
Hold
➜
Buy
|
Upgrade | Aug 05 2025 |
Needham |
Buy
➜
Buy
|
Unchanged | Aug 05 2025 |
Raymond James |
Outperform
➜
Outperform
|
Unchanged | Aug 05 2025 |
JMP Securities |
Market Outperform
➜
Market Outperform
|
Unchanged | Jul 22 2025 |
JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Jul 17 2025 |
Analyst Rating | Date |
---|---|
Unchanged
B of A Securities:
Buy
➜
Buy
|
Aug 06 2025 |
Unchanged
UBS:
Neutral
➜
Neutral
|
Aug 05 2025 |
Upgrade
Craig-Hallum:
Hold
➜
Buy
|
Aug 05 2025 |
Unchanged
Needham:
Buy
➜
Buy
|
Aug 05 2025 |
Unchanged
Raymond James:
Outperform
➜
Outperform
|
Aug 05 2025 |
Unchanged
JMP Securities:
Market Outperform
➜
Market Outperform
|
Jul 22 2025 |
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Jul 17 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.